The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pan-cancer discovery of clinical and genomic determinants of immune-related adverse events.
 
Ziad Bakouny
Honoraria - UpToDate
Patents, Royalties, Other Intellectual Property - Hold a provisional patent issued by MSKCC on immune-related adverse event prediction
(OPTIONAL) Uncompensated Relationships - ASCO IMG Community of Practice; IMG Oncologists (NGO)
 
X. Alex Guo
No Relationships to Disclose
 
Rohan Walser
No Relationships to Disclose
 
Feiyang Huang
Patents, Royalties, Other Intellectual Property - Diotex Diagnostics LLC
 
Saksham Mohan
No Relationships to Disclose
 
Tomin Perea-Chamblee
No Relationships to Disclose
 
Christopher Fong
Stock and Other Ownership Interests - Various biotech ETFs
Patents, Royalties, Other Intellectual Property - Imaging interfaces for full finger and full hand optical tomography; Monitoring Treatment of Peripheral Artery Disease (PAD) using Diffuse Optical Imaging; Systems and methods for dynamic imaging of tissue using digital optical tomography; Ultra-Wideband Radar System for Animals Patent Sep 11, 2018 Patent issuer and numberus US20150181840A1
 
Karl Pichotta
No Relationships to Disclose
 
Michele Waters
No Relationships to Disclose
 
Antonio Ocejo
No Relationships to Disclose
 
David Faleck
Consulting or Advisory Role - AstraZeneca; Gilead Sciences
Research Funding - Janssen Research & Development
 
Nikolaus Schultz
Honoraria - OneOncology
 
Justin Jee
Stock and Other Ownership Interests - Microsoft
Patents, Royalties, Other Intellectual Property - Patient license, MDSeq Inc
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Microsoft
 
Adam Schoenfeld
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb; cTRL; Foresight Diagnostics; GlaxoSmithKline; Immunocore; Iovance Biotherapeutics; Obsidian Therapeutics; Oxford BioTherapeutics; Prelude Therapeutics; Regeneron; Roche; Synthekine
Research Funding - AffiniT therapeutics (Inst); Amgen (Inst); AstraZeneca; BioNTech SE; Bristol-Myers Squibb (Inst); Clasp Therapeutics (Inst); GlaxoSmithKline (Inst); Harpoon therapeutics (Inst); Iovance Biotherapeutics (Inst); Legend Biotech (Inst); Lilly; Merck (Inst); PACT Pharma (Inst); Roche/Genentech; Synthekine (Inst)
Travel, Accommodations, Expenses - Iovance Biotherapeutics; Legend Biotech; Obsidian Therapeutics; Regeneron
Other Relationship - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
 
Ritesh Kotecha
Consulting or Advisory Role - Eisai; Eisai; Guidepoint Inc; Guidepoint Inc; Merck
Research Funding - Allogene Therapeutics (Inst); ArsenalBio (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Xencor (Inst)
 
Robert Motzer
Consulting or Advisory Role - Merck
Research Funding - Aveo (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Merck (Inst); Pfizer (Inst)
 
Craig Thompson
Leadership - Agios; Charles River Laboratories; Regeneron
Stock and Other Ownership Interests - Charles River Laboratories; Regeneron
Patents, Royalties, Other Intellectual Property - 30+ issued patents, royalties issued by U. Michigan, U Chicago, U Pennsylvania, and Elsevier
 
Jian Carrot-Zhang
No Relationships to Disclose
 
Wesley Tansey
No Relationships to Disclose
 
Eduard Reznik
Patents, Royalties, Other Intellectual Property - Hold a provisional patent issued by MSKCC on immune-related adverse event prediction